TMCO1, as a potential biomarker of prognosis and immunotherapy response, regulates head and neck squamous cell carcinoma proliferation and migration

Abstract Transmembrane and coiled-coil domains 1 (TMCO1), an endoplasmic reticulum transmembrane protein, actively regulates intracellular Ca2+ concentration and is associated with poor prognosis in several cancers. This study shows that TMCO1 is a potential biological prognostic indicator and thera...

Full description

Saved in:
Bibliographic Details
Main Authors: Ting Li, Lu Chen, Guangkai Zhou, Yuhan Deng, Meng Zhou, Mingze Yan, Shuyan Dong, Kaixun Xing, Shan Yu, Hongjiang He
Format: Article
Language:English
Published: Springer 2025-05-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-02437-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849314842260799488
author Ting Li
Lu Chen
Guangkai Zhou
Yuhan Deng
Meng Zhou
Mingze Yan
Shuyan Dong
Kaixun Xing
Shan Yu
Hongjiang He
author_facet Ting Li
Lu Chen
Guangkai Zhou
Yuhan Deng
Meng Zhou
Mingze Yan
Shuyan Dong
Kaixun Xing
Shan Yu
Hongjiang He
author_sort Ting Li
collection DOAJ
description Abstract Transmembrane and coiled-coil domains 1 (TMCO1), an endoplasmic reticulum transmembrane protein, actively regulates intracellular Ca2+ concentration and is associated with poor prognosis in several cancers. This study shows that TMCO1 is a potential biological prognostic indicator and therapeutic target for head and neck squamous cell carcinoma (HNSCC) by regulating the proliferation and migration of cancer cells, especially migration. We obtained TMCO1 expression data of HNSCC and normal tissues from The Cancer Genome Atlas (TCGA) and other databases and verified them with immunohistochemical staining. The results showed that high TMCO1 expression was significantly associated with HNSCC survival and tumor progression and was an independent prognostic factor for HNSCC. In addition, nomogram and receiver operating characteristic (ROC) curve, gene ontology, gene concentration and gene network analysis were used to reveal the function and regulatory mechanism of TMCO1. In vitro experiments confirmed that TMCO1 could promote proliferation, migration, invasion, adhesion and clonal formation of HNSCC cells. Furthermore, we analyzed the relationship between TMCO1 and tumor microenvironment, immune infiltration, immunotherapy and drug sensitivity, and found that patients with low TMCO1 expression were more suitable for immunotherapy, and suggested the selection of chemotherapy drugs. In conclusion, TMCO1 is a reliable biomarker in HNSCC, offering valuable guidance for clinical diagnosis and therapeutic strategies. These findings highlight its potential as a target for precision oncology in HNSCC.
format Article
id doaj-art-efbf997bcb714318b419af6b5adc27ca
institution Kabale University
issn 2730-6011
language English
publishDate 2025-05-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj-art-efbf997bcb714318b419af6b5adc27ca2025-08-20T03:52:19ZengSpringerDiscover Oncology2730-60112025-05-0116111710.1007/s12672-025-02437-yTMCO1, as a potential biomarker of prognosis and immunotherapy response, regulates head and neck squamous cell carcinoma proliferation and migrationTing Li0Lu Chen1Guangkai Zhou2Yuhan Deng3Meng Zhou4Mingze Yan5Shuyan Dong6Kaixun Xing7Shan Yu8Hongjiang He9Department of Head and Neck Surgery, Harbin Medical University Cancer HospitalDepartment of Pathology, Second Affiliated Hospital of Harbin Medical UniversityDepartment of Head and Neck Surgery, Harbin Medical University Cancer HospitalDepartment of Breast Surgery, Harbin Medical University Cancer HospitalDepartment of Anesthesiology, Harbin Medical University Cancer HospitalDepartment of Head and Neck Surgery, Harbin Medical University Cancer HospitalDepartment of Head and Neck Surgery, Harbin Medical University Cancer HospitalDepartment of Head and Neck Surgery, Harbin Medical University Cancer HospitalDepartment of Pathology, Second Affiliated Hospital of Harbin Medical UniversityDepartment of Head and Neck Surgery, Harbin Medical University Cancer HospitalAbstract Transmembrane and coiled-coil domains 1 (TMCO1), an endoplasmic reticulum transmembrane protein, actively regulates intracellular Ca2+ concentration and is associated with poor prognosis in several cancers. This study shows that TMCO1 is a potential biological prognostic indicator and therapeutic target for head and neck squamous cell carcinoma (HNSCC) by regulating the proliferation and migration of cancer cells, especially migration. We obtained TMCO1 expression data of HNSCC and normal tissues from The Cancer Genome Atlas (TCGA) and other databases and verified them with immunohistochemical staining. The results showed that high TMCO1 expression was significantly associated with HNSCC survival and tumor progression and was an independent prognostic factor for HNSCC. In addition, nomogram and receiver operating characteristic (ROC) curve, gene ontology, gene concentration and gene network analysis were used to reveal the function and regulatory mechanism of TMCO1. In vitro experiments confirmed that TMCO1 could promote proliferation, migration, invasion, adhesion and clonal formation of HNSCC cells. Furthermore, we analyzed the relationship between TMCO1 and tumor microenvironment, immune infiltration, immunotherapy and drug sensitivity, and found that patients with low TMCO1 expression were more suitable for immunotherapy, and suggested the selection of chemotherapy drugs. In conclusion, TMCO1 is a reliable biomarker in HNSCC, offering valuable guidance for clinical diagnosis and therapeutic strategies. These findings highlight its potential as a target for precision oncology in HNSCC.https://doi.org/10.1007/s12672-025-02437-yHNSCCTMCO1PrognosisBiomarkerImmunotherapy
spellingShingle Ting Li
Lu Chen
Guangkai Zhou
Yuhan Deng
Meng Zhou
Mingze Yan
Shuyan Dong
Kaixun Xing
Shan Yu
Hongjiang He
TMCO1, as a potential biomarker of prognosis and immunotherapy response, regulates head and neck squamous cell carcinoma proliferation and migration
Discover Oncology
HNSCC
TMCO1
Prognosis
Biomarker
Immunotherapy
title TMCO1, as a potential biomarker of prognosis and immunotherapy response, regulates head and neck squamous cell carcinoma proliferation and migration
title_full TMCO1, as a potential biomarker of prognosis and immunotherapy response, regulates head and neck squamous cell carcinoma proliferation and migration
title_fullStr TMCO1, as a potential biomarker of prognosis and immunotherapy response, regulates head and neck squamous cell carcinoma proliferation and migration
title_full_unstemmed TMCO1, as a potential biomarker of prognosis and immunotherapy response, regulates head and neck squamous cell carcinoma proliferation and migration
title_short TMCO1, as a potential biomarker of prognosis and immunotherapy response, regulates head and neck squamous cell carcinoma proliferation and migration
title_sort tmco1 as a potential biomarker of prognosis and immunotherapy response regulates head and neck squamous cell carcinoma proliferation and migration
topic HNSCC
TMCO1
Prognosis
Biomarker
Immunotherapy
url https://doi.org/10.1007/s12672-025-02437-y
work_keys_str_mv AT tingli tmco1asapotentialbiomarkerofprognosisandimmunotherapyresponseregulatesheadandnecksquamouscellcarcinomaproliferationandmigration
AT luchen tmco1asapotentialbiomarkerofprognosisandimmunotherapyresponseregulatesheadandnecksquamouscellcarcinomaproliferationandmigration
AT guangkaizhou tmco1asapotentialbiomarkerofprognosisandimmunotherapyresponseregulatesheadandnecksquamouscellcarcinomaproliferationandmigration
AT yuhandeng tmco1asapotentialbiomarkerofprognosisandimmunotherapyresponseregulatesheadandnecksquamouscellcarcinomaproliferationandmigration
AT mengzhou tmco1asapotentialbiomarkerofprognosisandimmunotherapyresponseregulatesheadandnecksquamouscellcarcinomaproliferationandmigration
AT mingzeyan tmco1asapotentialbiomarkerofprognosisandimmunotherapyresponseregulatesheadandnecksquamouscellcarcinomaproliferationandmigration
AT shuyandong tmco1asapotentialbiomarkerofprognosisandimmunotherapyresponseregulatesheadandnecksquamouscellcarcinomaproliferationandmigration
AT kaixunxing tmco1asapotentialbiomarkerofprognosisandimmunotherapyresponseregulatesheadandnecksquamouscellcarcinomaproliferationandmigration
AT shanyu tmco1asapotentialbiomarkerofprognosisandimmunotherapyresponseregulatesheadandnecksquamouscellcarcinomaproliferationandmigration
AT hongjianghe tmco1asapotentialbiomarkerofprognosisandimmunotherapyresponseregulatesheadandnecksquamouscellcarcinomaproliferationandmigration